# Effects of Saxagliptin on Adipose Tissue Inflammation in Humans

> **NCT02285985** · PHASE4 · COMPLETED · sponsor: **Phoenix VA Health Care System** · enrollment: 103 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus (T2DM)

## Interventions

- **DRUG:** Saxagliptin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02285985
- **Lead sponsor:** Phoenix VA Health Care System
- **Sponsor class:** FED
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02
- **Primary completion:** 2019-10-12
- **Final completion:** 2019-10-12
- **Target enrollment:** 103 (ACTUAL)
- **Last updated:** 2024-07-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02285985

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02285985, "Effects of Saxagliptin on Adipose Tissue Inflammation in Humans". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02285985. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*